Hindustan Times (Lucknow)

Anti-diabetes drug BGR-34 to be made more effective

- Pawan Dixit and Richa Srivastava lkoreporte­rsdesk@hindustant­imes.com

LUCKNOW: After the pan-India success and excellent reviews of anti-diabetes drug BGR-34, the NBRI and CIMAP have decided to carry out further research to make the medicine more effective.

The medicine – Blood Glucose Regulator 34 – has been jointly developed by the National Botanical Research Institute (NBRI) and the Central Institute for Medicinal and Aromatic Plants (CIMAP).

“Developed in the country, BGR-34 has proved to be a successful drug to fight Type-II diabetes. Its success story is now making waves all across the country,” said DK Upreti, acting director, NBRI.

“We have decided to carry out further research on BGR-34 to make it more effective,” added Upreti.

The NBRI has also roped in the Institute of Medical Sciences, Banaras Hindu University, for carrying out clinical trial of BGR-34.

“As part of the project, clinical trial of the drug will also be carried out at the IMS-BHU,” said Upreti.

BGR-34 is a combinatio­n of six best herbs listed in Ayurvedic texts for curing various ailments. The NBRI and the CIMAP selected these herbs after studying 500 ancient herbs.

The six herbs – Daruharidr­a (Berberis aristata), Giloy (Tinospora cordifolia), Vijayasar (Pterocarpu­s marsupium), Gudmar (Gymnema Sylvestre), Majeeth (Rubia Cordifolio) and Methika (Trigonella foenum – graecum) are essential ingredient­s of BGR- 34.

The NBRI also plans dedicated cultivatio­n of these six herbs used for producing BGR- 34.

The research institute would encourage farmers to go for exclusive farming of these herbs.

“Procuring the finest herbs for producing BGR-34 is also part of the new project. We will encourage farmers across the country to go for dedicated farming for six herbs used in developing this anti-diabetes Ayurvedic drug,” said AKS Rawat, senior scientist, NBRI, who is associated with the BGR-34 project.

Not only NBRI, farmers would also benefit from dedicated farming of herbs, added Rawat. BGR- 34 is being marketed in India by the pharmaceut­ical company – AIMIL Pharmaceut­icals (India).

Newspapers in English

Newspapers from India